Table 2.
Laboratory Findings on Admission in the Discharged and Death Groups
| Total (n = 141) | Discharged (n = 123) | Death (n = 18) | Ρ value | |
|---|---|---|---|---|
| WBC- × 109/L, median (IQR) | 6.3(5.0–8.4) | 6.2(5.0–8.1) | 8.6(5.2–14.9) | 0.064 |
| > 10-no.(%) | 18(12.8) | 10(8.1) | 8(44.4) | 0.000 |
| Lymphocyte- × 109/L, median (IQR) | 1.2(1.0–1.6) | 1.3(1.0–1.6) | 1.0(0.7–1.4) | 0.010 |
| ≤1.1-no. (%) | 57(40.4) | 44(35.8) | 13(72.2) | 0.003 |
| Neutrophil- × 109/L, median (IQR) | 4.0(3.0–6.2) | 3.9(2.9–5.8) | 7.2(3.1–13.9) | 0.022 |
| > 6.3-no. (%) | 34(24.1) | 24(19.5) | 10(55.6) | 0.002 |
| Platelet- × 109/L, median (IQR) | 225.0(163.5–296.0) | 234.0(172.0–301.0) | 134(96.5–217.0) | 0.001 |
| ≤100-no. (%) | 10(7.1) | 5(4.1) | 5(27.8) | 0.002 |
| RBC- × 1012/L, median (IQR) | 3.9(3.6–4.3) | 3.9(3.6–4.3) | 3.7(3.0–4.0) | 0.023 |
| ≤4.0-no. (%) | 84(59.6) | 70(56.9) | 14(77.8) | 0.092 |
| Hemoglobin- g/L, median (IQR) | 120.0(109.5–130.0) | 121.0(111.0–131.0) | 112.0(100.0–119.0) | 0.009 |
| ≤110-no. (%) | 38(27.0) | 30(24.4) | 8(44.4) | 0.132 |
| CRP-mg/L, median (IQR) | 13.2(3.2–39.1) | 9.0(3.1–28.8) | 106.0(21.9–150.0) | 0.000 |
| > 5.0-no. (%) | 100(70.9) | 82(66.7) | 18(100.0) | 0.004 |
| Procalcitonin-ng/L, median (IQR) | 40.0(20.0–100.0) | 40.0(20.0–70.0) | 360.0(97.5–1235.0) | 0.000 |
| > 500-no. (%) | 9(6.4) | 1(0.8) | 8(44.4) | 0.000 |
| D-dimer-mg/L, median (IQR) | 0.9(0.8–3.4) | 0.9(0.8–2.7) | 3.1(2.1–12.1) | 0.000 |
| > 1.0-no. (%) | 69(48.9) | 52(42.3) | 17(94.4) | 0.000 |
| Creatinine-μmol/L, median (IQR) | 69.0(58.0–98.0) | 68.0(57.0–94.0) | 96.0(64.3–133.3) | 0.026 |
| > 97-no. (%) | 36(25.5) | 27(22.0) | 9(50.0) | 0.024 |
| BUN-mmol/L, median (IQR) | 6.3(4.4–8.3) | 5.4(4.1–7.5) | 9.8(6.8–13.6) | 0.000 |
| > 7.1-no. (%) | 47(33.3) | 35(28.5) | 12(66.7) | 0.001 |
| AST-IU/L, median (IQR) | 25.0(20.0–33.5) | 24.0(19.0–31.0) | 33.0(23.8–55.5) | 0.005 |
| > 35-no. (%) | 31(22.0) | 24(19.5) | 7(38.9) | 0.121 |
| ALT-IU/L, median (IQR) | 19.0(13.0–26.5) | 18.0(13.0–27.0) | 22.0(13.0–27.3) | 0.500 |
| > 45-no. (%) | 14(9.9) | 14(11.4) | 0(0.0) | 0.277 |
| LDH- IU/L, median (IQR) | 218.0(168.5–327.5) | 201.0(160.0–275.0) | 485.5(257.3–811.3) | 0.000 |
| > 250-no. (%) | 51(36.2) | 37(30.1) | 14(77.8) | 0.000 |
| TB-μmol/L, median (IQR) | 11.5(9.1–15.7) | 11.5(9.1–14.8) | 12.5(9.0–18.0) | 0.695 |
| > 24-no. (%) | 15(10.6) | 12(9.8) | 3(16.7) | 0.632 |
| Hs-TnI-ng/L, median (IQR) | 14.0(8.0–25.0) | 12.0(7.0–22.0) | 41.0(24.8–168.0) | 0.000 |
| > 26-no. (%) | 31(22.0) | 18(14.6) | 13(72.2) | 0.000 |
| CK-MB-IU/L, median (IQR) | 7.0(5.0–11.0) | 7.0(5.0–10.0) | 8.5(4.8–13.0) | 0.205 |
| > 24-no. (%) | 4(2.8) | 2(1.6) | 2(11.1) | 0.079 |
| CK-IU/L, median (IQR) | 49.0(31.0–77.0) | 44.0(30.0–70.0) | 95.0(40.3–156.5) | 0.010 |
| > 170-no. (%) | 11(7.8) | 8(6.5) | 3(16.7) | 0.303 |
| NT-proBNP-ng/L,median (IQR) | 290.0(150.8–819.0) | 260.0(124.0–512.0) | 2362.5(1707.6–2978.3) | 0.000 |
| > 1800-no. (%) | 21(14.9) | 8(6.5) | 13(72.2) | 0.000 |
| Ground-glass opacity lesions on CT | 0.006 | |||
| 1–2 lung lobes, no. (%) | 88(62.4) | 82(66.7) | 6(33.3) | . |
| ≥ 3 lung lobes, no. (%) | 53(37.6) | 41(33.3) | 12(66.7) |
P values denoted the comparison between Discharged and Death groups. IQR interquartile range, WBC white blood cell, RBC red blood cell, CRP C reaction protein, BUN blood urea nitrogen, AST aspartateaminotransferase, ALT alanineaminotransferase, LDH lactic dehydrogenase, TB total bilirubin, Hs-TnI hypersensitive troponin I, CK-MB creatinekinase-MB, CK creatine kinase, NT-proBNP N-terminal pro-brain natriuretic peptide, CT computed tomography